Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study

PURPOSE: To investigate the safety and efficacy of lobaplatin-TACE in treating primary hepatocellular carcinoma. METHODS: The data of 536 patients who underwent TACE in the interventional department from January 2016 to January 2020 were collected. Patients were divided into two groups according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haohao, Zheng, Chuansheng, Liang, Bin, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Medicine, Oncology, Drug Design, Discovery and Therapy, Drug Design & Discovery, Chemistry, Medicinal Chemistry, Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186371/
https://www.ncbi.nlm.nih.gov/pubmed/35652401
http://dx.doi.org/10.2174/1871520622666220601115458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186371/
https://www.ncbi.nlm.nih.gov/pubmed/35652401
http://dx.doi.org/10.2174/1871520622666220601115458

Ejemplares similares